<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>122(11)</volume><submitter>Planquette B</submitter><funding>Groupe Hospitalier Paris Saint Joseph</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4> D-dimer measurement is a safe tool to exclude pulmonary embolism (PE), but its specificity decreases in coronavirus disease 2019 (COVID-19) patients. Our aim was to derive a new algorithm with a specific D-dimer threshold for COVID-19 patients.&lt;h4>Methods&lt;/h4> We conducted a French multicenter, retrospective cohort study among 774 COVID-19 patients with suspected PE. D-dimer threshold adjusted to extent of lung damage found on computed tomography (CT) was derived in a patient set (&lt;i>n&lt;/i&gt; = 337), and its safety assessed in an independent validation set (&lt;i>n&lt;/i> = 337).&lt;h4>Results&lt;/h4> According to receiver operating characteristic curves, in the derivation set, D-dimer safely excluded PE, with one false negative, when using a 900 ng/mL threshold when lung damage extent</pubmed_abstract><journal>Thrombosis and haemostasis</journal><pagination>1888-1898</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9626028</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD).</pubmed_title><pmcid>PMC9626028</pmcid><pubmed_authors>Soudet S</pubmed_authors><pubmed_authors>Goudot G</pubmed_authors><pubmed_authors>Sanchez O</pubmed_authors><pubmed_authors>Rance B</pubmed_authors><pubmed_authors>Emmerich J</pubmed_authors><pubmed_authors>Mirault T</pubmed_authors><pubmed_authors>Meneveau N</pubmed_authors><pubmed_authors>Fournier L</pubmed_authors><pubmed_authors>Chatellier G</pubmed_authors><pubmed_authors>Berre AL</pubmed_authors><pubmed_authors>Sevestre MA</pubmed_authors><pubmed_authors>Mao RL</pubmed_authors><pubmed_authors>Gendron N</pubmed_authors><pubmed_authors>Besutti M</pubmed_authors><pubmed_authors>Hamoud AA</pubmed_authors><pubmed_authors>Kahf SA</pubmed_authors><pubmed_authors>Couturaud F</pubmed_authors><pubmed_authors>Messas E</pubmed_authors><pubmed_authors>Yanoutsos A</pubmed_authors><pubmed_authors>Planquette B</pubmed_authors><pubmed_authors>Smadja DM</pubmed_authors><pubmed_authors>Chocron R</pubmed_authors><pubmed_authors>Khider L</pubmed_authors><pubmed_authors>Pernod G</pubmed_authors><pubmed_authors>Philippe A</pubmed_authors><pubmed_authors>Ferretti G</pubmed_authors><pubmed_authors>Diehl JL</pubmed_authors><pubmed_authors>Mohamedi N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD).</name><description>&lt;h4>Objective&lt;/h4> D-dimer measurement is a safe tool to exclude pulmonary embolism (PE), but its specificity decreases in coronavirus disease 2019 (COVID-19) patients. Our aim was to derive a new algorithm with a specific D-dimer threshold for COVID-19 patients.&lt;h4>Methods&lt;/h4> We conducted a French multicenter, retrospective cohort study among 774 COVID-19 patients with suspected PE. D-dimer threshold adjusted to extent of lung damage found on computed tomography (CT) was derived in a patient set (&lt;i>n&lt;/i&gt; = 337), and its safety assessed in an independent validation set (&lt;i>n&lt;/i> = 337).&lt;h4>Results&lt;/h4> According to receiver operating characteristic curves, in the derivation set, D-dimer safely excluded PE, with one false negative, when using a 900 ng/mL threshold when lung damage extent</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T19:35:01.841Z</modification><creation>2025-04-06T08:01:37.837Z</creation></dates><accession>S-EPMC9626028</accession><cross_references><pubmed>35144305</pubmed><doi>10.1055/a-1768-4371</doi></cross_references></HashMap>